Biologic Treatments

Biologic medications are specifically designed to mimic chemicals that are naturally found within the human body, and act to correct something that is going wrong. A well-known biologic treatment (that is not used for psoriasis) is Insulin, which is taken by diabetics.

The National Institute for Health and Care Excellence (NICE) has issued guidelines for when biologics can be prescribed. NICE recommends that Adalimumab (Humira, Amgevita, Hulio, Hyrimoz and Imraldi), Enbrel (Etanercept), Stelara (Ustekinumab), Cosentyx (Secukinumab), Kyntheum (Brodalumab), Taltz (Ixekizumab), Tremfya (Guselkumab), Cimzia (Certolizumab pegol), Skyrizi (Risankizumab) and Ilumetri (Tildrakizumab) can be prescribed for people with severe psoriasis who have not responded to systemic treatments such as PUVA, methotrexate, ciclosporin and acitretin.

People can also be prescribed these biologics if the mentioned systemics cause side effects which means the person should not take them, or if the person has another condition or medication which means that they should not take the other systemic treatments. Remicade (Infliximab) can be offered for the treatment of very severe plaque psoriasis if the psoriasis has not responded to other systemic treatments such as PUVA, methotrexate or ciclosporin.

Click on the links below to find out more about the different types of biologics available to treat psoriasis.

Adalimumab (Humira, Amgevita, Hulio, Hyrimoz  and Imraldi)

Cimzia (Certolizumab pegol)

Cosentyx (Secukinumab)

Enbrel (Etanercept)

Ilumetri (Tildrakizumab)

Kyntheum (Brodalumab)

Remicade (Infliximab)

Skyrizi (Risankizumab)

Stelara (Ustekinumab)

Taltz (Ixekizumab)

Tremfya (Guselkumab)

For more information, or for a list of resources used in the production of this information, please contact us.

We use cookies to help us provide you with a better service, but do not track anything that can be used to personally identify you. If you prefer us not to set these cookies, please visit our Cookie Settings page or continue browsing our site to accept them. Close